We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Melanoma Cells Retain a Functional Self-Destruct Mechanism

By LabMedica International staff writers
Posted on 14 Aug 2009
A team of American and Spanish cancer researchers has found that melanoma cells retain a mechanism for self-digestion and apoptosis that can be initiated if the correct trigger mechanism is activated.

Investigators from Virginia Commonwealth University (Richmond, USA) and the Spanish National Cancer Research Center (Madrid) employed both cellular systems and genetically engineered mouse models as they attempted to jump-start the autodestruct mechanism in melanoma cells.

The successful method was described in the August 4, 2009, issue of the journal Cancer Cell. More...
In this study, the investigators reported that the pathway begins with the melanoma differentiation-associated gene-5 (mda-5), which activates a protein called NOXA. The expression of NOXA (phorbol-12-myristate-13-acetate-induced protein 1) is regulated by the tumor-suppressor p53, and NOXA has been shown to be involved in p53-mediated apoptosis.

"The present research provides a path that could lead with further studies and a phase I clinical trial for safety to the development of a strategy that reenergizes the immune system to destroy this highly aggressive cancer,” said contributing author Dr. Paul B. Fisher, professor of human and molecular genetics at Virginian Commonwealth University.

Related Links:

Virginia Commonwealth University
Spanish National Cancer Research Center




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.